Antimicrobial resistance in internal medicine wards

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Antimicrobial resistance (AMR) is a critical global health issue impacting numerous bacterial pathogens.
• Key challenges include infections caused by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.

Purpose of the Study:

• To provide an overview of current epidemiological trends for major multi-drug resistant pathogens.
• To review the therapeutic options currently available for treating infections caused by these resistant bacteria.

Main Methods:

• Literature review of recent epidemiological data on multi-drug resistant pathogens.
• Analysis of current treatment guidelines and therapeutic strategies for infections caused by MRSA, VRE, ESBL-producers, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Main Results:

• Significant global prevalence of multi-drug resistant bacterial infections.
• Limited and often challenging therapeutic choices for infections caused by pathogens like MRSA, VRE, and carbapenemase-producing Enterobacteriaceae.

Conclusions:

• Urgent need for updated therapeutic strategies to combat rising antimicrobial resistance.
• Continued surveillance and development of novel treatments are essential to manage multi-drug resistant bacterial infections effectively.